Author:
Hartmann Jens,Jungen Christiane,Stec Sebastian,Klatt Niklas,Willems Stephan,Makimoto Hisaki,Steven Daniel,Pürerfellner Helmut,Martinek Martin,Meyer Christian
Abstract
Abstract
Background
Supraventricular tachycardias induced by dual antegrade conduction via the atrioventricular (AV) node are rare but often misdiagnosed with severe consequences for the affected patients. As long-term follow-up in these patients was not available so far, this study investigates outcomes in patients with dual antegrade conduction in the AV node.
Methods and results
In this multicentre observational study, patients from six European centres were studied. Catheter ablation was performed in 17 patients (52 ± 16 years) with dual antegrade conduction via both AV nodal pathways between 2012 and 2018. Patients with the final diagnosis of a manifest dual AV nodal non-re-entrant tachycardia had a mean delay of the correct diagnosis of over 1 year (range 2–31 months). Two patients received prescription of non-indicated oral anticoagulation, two further patients suffered from inappropriate shocks of an implantable cardioverter defibrillator. In 12 patients, a co-existence of dual antegrade and re-entry conduction in the AV node was present. Mean fast pathway conduction time was 138 ± 61 ms and mean slow pathway conduction time was 593 ± 134 ms. Successful radiofrequency catheter ablation was performed in all patients. Post-procedurally oral anticoagulation was discontinued, without detection of cerebrovascular events or atrial fibrillation during a long-term follow-up of median 17 months (range 6–72 months).
Conclusion
This first multicentre study investigating patients with supraventricular tachycardia and dual antegrade conduction in the AV node demonstrates that catheter ablation is safe and effective while long-term patient outcome is good. Autonomic tone dependent changes in ante- vs. retrograde conduction via slow and/or fast pathway can challenge the diagnosis and therapy in some patients.
Graphic abstract
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference37 articles.
1. Jackman WM, Beckman KJ, McClelland JH, Wang X, Friday KJ, Roman CA et al (1992) Treatment of supraventricular tachycardia due to atrioventricular nodal reentry by radiofrequency catheter ablation of slow-pathway conduction. N Engl J Med 327:313–318
2. Page RL, Joglar JA, Caldwell MA, Calkins H, Conti JB, Deal BJ et al (2016) 2015 ACC/AHA/HRS Guideline for the management of adult patients with supraventricular tachycardia: a report of the american college of cardiology/american heart association task force on clinical practice guidelines and the heart rhythm society. Circulation 133:e506–574
3. Lee KW, Badhwar N, Scheinman MM (2008) Supraventricular tachycardia—part I. Curr Probl Cardiol 33:467–546
4. Nakagawa H, Jackman WM (2007) Catheter ablation of paroxysmal supraventricular tachycardia. Circulation 116:2465–2478
5. Eckhardt LL, Leal M, Hollis Z, Tanega J, Alberte C (2012) Cryoablation for AVNRT: importance of ablation endpoint criteria. J Cardiovasc Electrophysiol 23:729–734
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献